66 related articles for article (PubMed ID: 25477336)
1. Folding of an intrinsically disordered protein by phosphorylation as a regulatory switch.
Bah A; Vernon RM; Siddiqui Z; Krzeminski M; Muhandiram R; Zhao C; Sonenberg N; Kay LE; Forman-Kay JD
Nature; 2015 Mar; 519(7541):106-9. PubMed ID: 25533957
[TBL] [Abstract][Full Text] [Related]
2. Inducible drug modification: a new form of resistance.
Culjkovic-Kraljacic B; Zahreddine HA; Borden KL
Cell Cycle; 2014; 13(16):2485-6. PubMed ID: 25486186
[No Abstract] [Full Text] [Related]
3. The eukaryotic translation initiation factor eIF4E in the nucleus: taking the road less traveled.
Osborne MJ; Borden KL
Immunol Rev; 2015 Jan; 263(1):210-23. PubMed ID: 25510279
[TBL] [Abstract][Full Text] [Related]
4. Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.
Pelletier J; Graff J; Ruggero D; Sonenberg N
Cancer Res; 2015 Jan; 75(2):250-63. PubMed ID: 25593033
[TBL] [Abstract][Full Text] [Related]
5. Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights.
Tian X; Yan T; Liu F; Liu Q; Zhao J; Xiong H; Jiang S
Front Pharmacol; 2022; 13():991052. PubMed ID: 36071839
[TBL] [Abstract][Full Text] [Related]
6. UGT1A Gene Family Members Serve as Potential Targets and Prognostic Biomarkers for Pancreatic Cancer.
Feng L; Wang Y; Qin J; Fu Y; Guo Z; Zhang J; He G; Jiang Z; Xu X; Zhou C; Gao Y
Biomed Res Int; 2021; 2021():6673125. PubMed ID: 34595239
[TBL] [Abstract][Full Text] [Related]
7. Overcoming Drug Resistance through the Development of Selective Inhibitors of UDP-Glucuronosyltransferase Enzymes.
Osborne MJ; Coutinho de Oliveira L; Volpon L; Zahreddine HA; Borden KLB
J Mol Biol; 2019 Jan; 431(2):258-272. PubMed ID: 30428301
[TBL] [Abstract][Full Text] [Related]
8. Targeted Dual pH-Sensitive Lipid ECO/siRNA Self-Assembly Nanoparticles Facilitate In Vivo Cytosolic sieIF4E Delivery and Overcome Paclitaxel Resistance in Breast Cancer Therapy.
Gujrati M; Vaidya AM; Mack M; Snyder D; Malamas A; Lu ZR
Adv Healthc Mater; 2016 Nov; 5(22):2882-2895. PubMed ID: 27723260
[TBL] [Abstract][Full Text] [Related]
9. Molecular Pathways: GLI1-Induced Drug Glucuronidation in Resistant Cancer Cells.
Zahreddine HA; Borden KL
Clin Cancer Res; 2015 May; 21(10):2207-10. PubMed ID: 25810373
[TBL] [Abstract][Full Text] [Related]
10. Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?
Borden KL; Culjkovic-Kraljacic B
Leuk Lymphoma; 2010 Oct; 51(10):1805-15. PubMed ID: 20629523
[TBL] [Abstract][Full Text] [Related]
11. Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyond.
Pettersson F; Del Rincon SV; Miller WH
Expert Opin Ther Targets; 2014 Sep; 18(9):1035-48. PubMed ID: 25004955
[TBL] [Abstract][Full Text] [Related]
12. When will resistance be futile?
Borden KL
Cancer Res; 2014 Dec; 74(24):7175-80. PubMed ID: 25477336
[TBL] [Abstract][Full Text] [Related]
13. The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation.
Zahreddine HA; Culjkovic-Kraljacic B; Assouline S; Gendron P; Romeo AA; Morris SJ; Cormack G; Jaquith JB; Cerchietti L; Cocolakis E; Amri A; Bergeron J; Leber B; Becker MW; Pei S; Jordan CT; Miller WH; Borden KL
Nature; 2014 Jul; 511(7507):90-3. PubMed ID: 24870236
[TBL] [Abstract][Full Text] [Related]
14. Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabine.
Assouline S; Gasiorek J; Bergeron J; Lambert C; Culjkovic-Kraljacic B; Cocolakis E; Zakaria C; Szlachtycz D; Yee K; Borden KLB
Haematologica; 2023 Nov; 108(11):2946-2958. PubMed ID: 36951168
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
